# SUGAMMADEX
> **ANDA218727** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA PHARMACEUTICALS USA INC · Approved 2025-06-27
## Drug
- **FDA Application Number:** ANDA218727
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUGAMMADEX
- **Generic name:** Sugammadex
- **Active ingredients:** SUGAMMADEX
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HIKMA PHARMACEUTICALS USA INC
- **First approval:** 2025-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218727)
---
*MORVS · CC0 1.0*